Latest news & articles
Changes to the Federal Government’s Insulin Pump Program
The Australian Government’s Insulin Pump Program (IPP), administered by JDRF Australia, provides insulin pumps to young Australians up to the age of 21, living with type 1 diabetes (T1D), who meet certain financial and clinical eligibility requirements. The program supplies fully subsidised insulin pumps to people who would otherwise be unable to access insulin pump […]
JDRF Australia announces changes to the Board
JDRF Australia, the leading organisation for type 1 diabetes (T1D) research, advocacy, and community support, is pleased to announce three additions to its Board of Directors, while at the same time farewelling two long-serving and highly valued current Directors. With a wealth of experience in the not-for-profit, insurance and investment management sectors, the three new […]
Advocacy Spotlight: Freya & Jackie Goldston
Freya has been living with type 1 diabetes (T1D) for 14 years, after being diagnosed at just 11 months old. Since then, Freya and her mum Jackie have been fiercely advocating for the T1D community on behalf of JDRF Australia. We spoke to both Freya and Jackie about their family’s journey with T1D and their […]
Fiasp insulin to remain on the Pharmaceutical Benefits Scheme
MEDIA RELEASE Fiasp insulin to remain on the Pharmaceutical Benefits Scheme The new listing of Fiasp® Penfill® on the Pharmaceutical Benefits Scheme will keep the life-saving medication available to the 15,000+ Australians who rely on it Sydney, 18 September 2023: JDRF Australia is welcoming an announcement from Minister for Health, Hon Mark Butler, that Fiasp […]
Advocacy spotlight: Reece & Brittany Wilson
At the age of 24, Reece suffered a stroke, and his wife Brittany was diagnosed with an aggressive form of breast cancer. Just nine months into her treatment, Reece was diagnosed with type 1 diabetes (T1D). “For a person living with T1D, the outcome of a cure, recovery or even remission is not an option.” […]
Ethan Greenfield heads to Washington D.C. for the 2023 JDRF International Children’s Congress
Ethan Greenfield has been living with type 1 diabetes (T1D) for seven years, after being diagnosed at just four years old. Since then, Ethan, mum Kylie, and the Greenfield family have been fiercely advocating for the T1D community on behalf of JDRF Australia. After years of involvement with JDRF and raising the profile of T1D, […]
How JDRF’s #AccessForAll Campaign Has Delivered Impact for The Type 1 Diabetes Community
JDRF Australia’s advocacy program exists to support two primary goals. Firstly, to help health policy progress at the same rate as type 1 diabetes (T1D) research, treatments and therapies, so that the type 1 community can access the benefits as soon as possible; and secondly, to secure funding to support JDRF’s research advancements. The program […]
$273.1m bipartisan commitment for T1D to transform access to glucose monitoring technology
JDRF Australia has welcomed a $273.1 million bipartisan commitment for increased access to glucose monitoring technology set to change disease management options for Australians with type 1 diabetes (T1D). Currently, many people lose access to this technology, which is shown to improve short and long-term T1D health outcomes, when they reach 21 and subsidisation lapses, […]
JDRF Australia welcomes significant commitment to improving lives of Australian type 1 diabetes (T1D) community
Coalition commitment of $273.1M will make technology access a reality for 130,000 Australians living with T1D. JDRF, Australia’s largest organisation dedicated to T1D research and advocacy, welcomes the significant commitment to T1D technology access announced today by Prime Minister Scott Morrison. Currently, many people lose access to this technology, which is shown to improve short- […]
Dexcom G6 CGM added to devices available through CGM Subsidy Initiative
The Dexcom G6 Continuous CGM system has been added to the devices available through the Australian Government’s CGM Subsidy Initiative.
Talking T1D advocacy with QLD Advocate Alyssa Zaini
Alyssa was diagnosed at age 8. She shares with us her experience of being diagnosed at a young age, and also her JDRF advocacy highlights.
MP Profile: A JDRF Q&A with Michelle Landry MP
MP meetings are a core part of JDRF advocacy, and this month we chatted with Michelle Landry MP on why she values JDRF advocate meetings.
Spotlight on our Government Leadership Group with Alex Selig
I joined the JDRF Government Leadership Group to educate Australian government and public on type 1 diabetes and improve access to technology.
$10M worth of new funding for diabetes research announced by Federal Government
Friday, January 14, 2022 JDRF and other diabetes organisations have welcomed the Federal Government’s announcement of $10 million over four years to establish the Australian Centre for Accelerating Diabetes Innovations (ACADI) at the University of Melbourne. The Centre will help turn vital medical research into better prevention, diagnosis and treatment for patients with all types of diabetes. The funding will be delivered through the […]
Spotlight on our Government Leadership Group with Debbie Smith
I joined the JDRF Government Leadership Group this year so I could help type 1 diabetes inequities be addressed by better government policy.
Talking T1D advocacy with QLD Lead Advocate Carrie Forbes
Carrie was diagnosed with type 1 diabetes when she was 5. She became a JDRF advocate so her voice could help others living with T1D.
MP Profile: A JDRF exclusive with David Smith MP
MP meetings are a core part of JDRF advocacy, and this month we chatted with David Smith MP on why he values JDRF advocate meetings.
#AccessForAll: JDRF launches new campaign to increase access to life saving and life changing technology
Life-saving and life-changing technologies to measure blood glucose and deliver insulin in response to need are the foundation of type 1 diabetes (T1D) treatment and care in the 21st century. But in Australia, access to these technologies is inconsistent, inequitable, and incomplete. Even worse, they cut out for many on adulthood. This needs to change. […]